141330-30-5

Basic information

• Product Name: (+/-)-2,3-Dihydro-7-(methoxymethoxy)-3-<4-(methoxymethoxy)phenyl>-4H-1-benzopyran-4-on
• Synonyms: (+/-)-2,3-Dihydro-7-(methoxymethoxy)-3-<4-(methoxymethoxy)phenyl>-4H-1-benzopyran-4-on
• CAS NO: 141330-30-5
• Molecular Weight: 344.364
• Mol File: 141330-30-5.mol

Chemical Properties

• CAS DataBase Reference: (+/-)-2,3-Dihydro-7-(methoxymethoxy)-3-<4-(methoxymethoxy)phenyl>-4H-1-benzopyran-4-on(CAS DataBase Reference)
• NIST Chemistry Reference: (+/-)-2,3-Dihydro-7-(methoxymethoxy)-3-<4-(methoxymethoxy)phenyl>-4H-1-benzopyran-4-on(141330-30-5)
• EPA Substance Registry System: (+/-)-2,3-Dihydro-7-(methoxymethoxy)-3-<4-(methoxymethoxy)phenyl>-4H-1-benzopyran-4-on(141330-30-5)

Safety Data

• Hazardous Substances Data: 141330-30-5(Hazardous Substances Data)

Upstream product

• 17238-05-0 dihydrodaidzein 
• 107-30-2 chloromethyl methyl ether 
• 141330-20-3 7-(Methoxymethoxy)-3-<4-(methoxymethoxy)phenyl>-4H-1-benzopyran-4-on 
• 141330-21-4 3-<2,4-Bis<(2-methoxyethoxy)methoxy>phenyl>-7-<(2-methoxyethoxy)methoxy>-4H-1-benzopyran-4-on 
• 113250-45-6 3-<2,4-Bis(methoxymethoxy)phenyl>-7-(methoxymethoxy)-4H-1-benzopyran-4-on 

Downstream Products

• 17238-05-0 dihydrodaidzein 
• 209324-95-8 4-(4-hydroxyphenyl)-4-hydroxy-7-methoxymethyloxy-3-[4-(methoxymethyloxy)phenyl]-2,3-dihydro-4H-benzopyran 
• 209324-81-2 7-methoxymethyloxy-3-[4-(methoxymethyloxy)phenyl]-3-methyl-2,3-dihydro-4H-benzopyran-4-one 

Relevant articles and documents

Enantioselective Synthesis of Isoflavanones by Catalytic Dynamic Kinetic Resolution

A ruthenium-catalyzed asymmetric transfer hydrogenation of racemic isoflavanones with dynamic kinetic resolution yields virtually enantiopure isoflavanols as single diastereomers. Subsequent oxidation gives rise to isoflavanones in high enantiomeric purit

Method for enantioselective hydrogenation of chromenes

A method for preparing an enantiomeric chromane, by asymmetrically hydrogenating a chromene compound in the presence of an Ir catalyst having a chiral ligand. The method includes the enantioselective preparation of enantiomeric equol. A preferred Ir catalyst has a chiral phosphineoxazoline ligand. Enantiomeric chromanes of high stereoselective purity can be obtained.